IL6 and breast cancer: Lastly, a recent study demonstrated that hypoxia-induced secretion of IL6 specifically by ERα+ breast cancer cells was capable of elevating both ERα+ and ERα− bCSC self-renewal and proliferation in a JAK-STAT pathway-dependent manner in vitro [164].